Flagship Harbor Advisors’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.38M | Buy |
|
|||||
|
2025
Q1 | $4.33M | Buy |
|
|||||
|
2024
Q4 | $3.29M | Sell |
|
|||||
|
2024
Q3 | $4.72M | Buy |
|
|||||
|
2024
Q1 | $3.87M | Buy |
|
|||||
|
2023
Q4 | $3.55M | Buy |
|
|||||
|
2023
Q3 | $2.89M | Buy |
|
|||||
|
2023
Q2 | $3.13M | Sell |
|
|||||
|
2023
Q1 | $5.11M | Sell |
|
|||||
|
2022
Q4 | $5.22M | Buy |
|
|||||
|
2022
Q3 | $4.86M | Buy |
|
|||||
|
2022
Q2 | $4.92M | Buy |
|
|||||
|
2022
Q1 | $5.61M | Buy |
|
|||||
|
2021
Q4 | $6.44M | Buy |
|
|||||
|
2021
Q3 | $6.95M | Hold |
|
|||||
|
2021
Q2 | $6.95M | Buy |
|
|||||
|
2021
Q1 | $6.35M | Buy |
|
|||||
|
2020
Q4 | $6.01M | Buy |
|
|||||
|
2020
Q3 | $5.16M | Buy |
|
|||||
|
2020
Q2 | $5.12M | Buy |
|
|||||
|
2020
Q1 | $4.16M | Buy |
|
|||||
|
2019
Q4 | $4.82M | Sell |
|
|||||
|
2019
Q3 | $4.25M | Buy |
|
|||||
|
2019
Q2 | $4.63M | Buy |
|
|||||
|
2019
Q1 | $4.59M | Buy |
|
|||||
|
2018
Q4 | $3.84M | Buy |
|
|||||
|
2018
Q3 | $5.07M | Buy |
|
|||||
|
2018
Q2 | $4.66M | Buy |
|
|||||
|
2018
Q1 | $4.26M | Buy |
|
|||||
|
2017
Q4 | $4.18M | Buy |
|
|||||
|
2017
Q3 | $4.44M | Buy |
|
|||||
|
2017
Q2 | $4.02M | Buy |
|
|||||
|
2017
Q1 | $3.44M | Buy |
|
|||||
|
2016
Q4 | $2.91M | Buy |
|